Termination of Information Rights. The covenants set forth in Subsection 3.1 and Subsection 3.2 shall terminate and be of no further force or effect immediately before the consummation of the IPO.
Appears in 2 contracts
Samples: Investor Rights Agreement (Actuate Therapeutics, Inc.), Investor Rights Agreement (Actuate Therapeutics, Inc.)
Termination of Information Rights. The covenants set forth in Subsection 3.1 and Subsection 3.2 shall terminate and be of no further force or effect immediately before the consummation of the IPO[***].
Appears in 2 contracts
Samples: Investors’ Rights Agreement (PureTech Health PLC), Investors’ Rights Agreement (PureTech Health PLC)
Termination of Information Rights. The covenants set forth in Subsection 3.1 Subsections 4.1, 4.2 and Subsection 3.2 4.3 shall terminate and be of no further force or effect immediately before the consummation of the IPO[***].
Appears in 2 contracts
Samples: Investors’ Rights Agreement (PureTech Health PLC), Investors’ Rights Agreement (PureTech Health PLC)
Termination of Information Rights. The covenants set forth in Subsection 3.1 Subsections 4.1, 4.2 and Subsection 3.2 4.3 shall terminate and be of no further force or effect immediately before the consummation of the IPOupon [***].
Appears in 1 contract
Termination of Information Rights. The covenants set forth in Subsection Sections 3.1 and Subsection 3.2 shall terminate and be of no further force or effect immediately before upon the consummation of the IPOQualified Initial Public Offering.
Appears in 1 contract
Samples: Investors’ Rights Agreement (Decipher Biosciences, Inc.)
Termination of Information Rights. The covenants set forth in Subsection 3.1 Subsections 4.1, 4.2 and Subsection 3.2 4.3 shall terminate and be of no further force or effect immediately before the consummation of the IPO.[***]
Appears in 1 contract
